4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 4 of 4 clinical reviews.
A clinician-facing review of how Hispanic / Latino ancestry affects the safety, pharmacogenomics, and dosing of oral micronized progesterone (Prometrium), covering CYP2C19 variants, diabetes risk, and ethnicity-stratified trial data.
Evidence-based review of oral micronized progesterone (Prometrium) efficacy differences in East Asian populations, covering CYP enzyme polymorphisms, dosing adjustments, and ethnicity-stratified clinical data.
Evidence-based review of how oral micronized progesterone (Prometrium) performs in Hispanic and Latino patients, including pharmacogenomic factors, metabolic interactions, and clinical considerations for dosing.
A clinician-focused guide to oral micronized progesterone (Prometrium) dosing in South Asian patients, covering pharmacogenomics, CYP2C19 variability, cardiovascular risk context, and evidence-based dose adjustment strategies.